Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Do these have any life left in them or have they run out?
NXGT - OS - 69,479,689 - 09/01/2021 Looking to acquire $100,000,000 + like Businesses, also keep this in mind
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=164876945
Sales
Debt
Share Structure
Insider Ownership %
fill me in on the deets
NXGT MEDICAL PLAY - Float - 25,864,090 - 06/30/2021
$NXGT Float - 25,864,090 - 06/30/2021https://t.co/tYBDFURJ1T#Stocks Buy Back Initiativehttps://t.co/KdVrcLRe7U#OTCQX Uplistinghttps://t.co/KdVrcLRe7U#Merger #Acquisitionshttps://t.co/KdVrcLRe7U$MTRT $BBIG $CEI $PHHRF $IBGR $CLNV $RGBP $NSAV $VXIT $LCLP $EEENF $ASTA pic.twitter.com/1a5u6ZUZmF
— PENNIES to STACKS (@PENNIEStoSTACKS) September 1, 2021
Breakout Boards
Rank Board Rate* Posts Today News Quote** Last Change Chg% Volume ?***
1 Galaxy Next Generation Inc. (GAXY) 1,591% 350 GAXY 0.008 0.0038 90.48% 63,988,549
Okay..
After all the NONSENSE fighting.
I see us going up again..
GILEAD FDA APPROVE?
WE ROCK FOLKS.
$LGND
$LGNDZ
PEOPLE NEEDS TO SEE AND READ AND SEE THE SP WHILE THEY'RE READING THE BOARD.
ALL THEY SEE IS A WHOPPING $77+ TICKER SYMBOL.
SHIT..
THEY'LL JUST SKIP.
That is why I have stopped posting there
it confuses new playas when they see $77+ pps ticker without any of LGDNZ or any other CVR prices on the main LIGAND board.
Plus all that immature fighting like 12 years old.
Unfortunately
Just as I thought.
ALL THE FIGHTING AND ALL THE BS..
the tickers tank
Vaccine for COVID-19 (TRUMP is gonna Talk about this stock!).$INO.
https://www.msn.com/en-us/health/medical/inovio-pharmaceuticals-plans-first-dosing-of-patients-in-trial-of-dna-covid-19-vaccine-candiate-on-monday/ar-BB12dS1u
$INO
cratering..
but did have 2 huge up days
$LGNYZ ~~~~> Big time mover this week!
LGNYZ is a BIG TIME PLAYER THIS WEEK
LIGAND PROVIDES A CORPORATE UPDATE AND ANNOUNCES MAY 6TH AS THE DATE FOR FIRST QUARTER EARNINGS CALL
https://investor.ligand.com/press-releases/detail/410/ligand-provides-a-corporate-update-and-announces-may-6th-as
$LGNDZ: Listen to Dr.StableGenius......
And you die.
https://www.forbes.com/sites/tarahaelle/2020/03/23/man-dead-from-taking-chloroquine-after-trump-touts-drug-for-coronavirus/
GO $LGNDZ
Amazing stuff TY so much for posting. So this is for LGNDZ?
Anytime. If you have any other CVR plays ... please feel free to post. We will see enough LGND posts here over the next few weeks that we are going to need to balance things out here
Yes, got that. Thank you for invite
Thats good .... the way this board is set up is that we can post about all biotech cvr's equally but the board CANNOT be a 100% substitute for the LGND board. If all posts are about LGND and LGND* constantly .... admin WILL shut this board down.
Yes,LGNDZ$$$_$$$$$. I like that then we don't have to deal with the puppet popping off its mouth every second.
BINGO! Golden ticket plays ~~> $LGND*
Here's the connection: GILD's COVID-19's drug Remdesivir needs LGND's drug Captisol to work.
Mereo BioPharma Announces Update on Distribution Related to Contingent Value Rights Following Recent Oncologie Licensing Agreement for Navicixizumab
https://www.biospace.com/article/releases/mereo-biopharma-announces-update-on-distribution-related-to-contingent-value-rights-following-recent-oncologie-licensing-agreement-for-navicixizumab/
An All-or-Nothing Bet on 3 Drugs in Celgene’s Pipeline
https://www.barrons.com/articles/with-bristol-myers-cvr-investors-can-bet-on-3-drugs-in-celgenes-pipeline-51574269284
Correct and the quietness on LGND is about to end. Think about it .... GILD gets positive FDA news .... LGND has the ingredient that makes GILD CV19 vaccine work ... someone is going to look at LGND as a buy out option. One step at a time but it is coming ... keep an eye out for FDA news :)
yes i am aware. biggest frustration of LGND reg. shares have been just that... mkt seems to be asleep on LGND (vs GILD which is getting the attention, rightfully so). LGND is so undervalued..
GILD will prob be > $100 once CV drug is 'approved' - how can they NOT approve imo.... for many reasons.
Also ... we are on GILD news watch from the FDA
These cvr's have been undervalued for a long time. They are now moving forward. Really ... in a perfect world .... these cvr's should reflect about 10% of the parent stock. We shall soon see .... the opening for all cvr's should be huge.
thanks for the postings. appreciate it man.
still not sure what would be driving this 10X + increase just in a few days with few of these CVs associated with LGND.
I mean I hold LGND for many years and I do know they are 'supporting' GILD's Coronavirus drug (potentially) but the regular shares have been stagnant at best.. yet these CVs are rocketing higher. I just don't get the link
If you are viewing this on mobile, it may be all run together without paragraph formatting. Best to view on a desktop or laptop where the formatting is correct. Good luck to all - feed back encouraged. randy
The following are the CONTINGENT VALUE RIGHTS Agreements and links to SEC Filings for;
Ligand pharmaceuticals Inc. (LGND) Nasdaq - FORM 8-K January 27, 2010
https://www.sec.gov/Archives/edgar/data/886163/000119312510015242/d8k.htm
There is an individual SEC filing for each CRV below as well.
LGNDZ
=====
https://www.sec.gov/Archives/edgar/data/886163/000119312510015242/dex101.htm
Roche Contingent Value Rights Agreement, by and among Ligand Pharmaceuticals Incorporated, Metabasis Therapeutics, Inc., David F. Hale, as Stockholders’ Representative, and Mellon Investor Services LLC as Rights Agent, dated January 27, 2010
Roche CVR. The Roche CVR Agreement entitles each holder of a Roche CVR to receive a pro rata portion of 65% of any milestone payments or 68% of any royalties paid by Roche under Metabasis’ partnered drug development program with Roche in hepatitis C, or 65% of the net proceeds of any sale of those program rights.
=================
The following are CRV's from the Acquisition of Metabasis Therapeutics, Inc. on January 28, 2010
News Release on the Merger Completion of ligand and Metabasis Therapeutics, Inc.,: https://www.businesswire.com/news/home/20100128005321/en/Ligand-Completes-Acquisition-Metabasis
https://www.sec.gov/Archives/edgar/data/886163/000119312510015242/0001193125-10-015242-index.htm
LGNZZ
=====
https://www.sec.gov/Archives/edgar/data/886163/000119312510015242/dex102.htm
TR Beta Contingent Value Rights Agreement, by and among Ligand Pharmaceuticals Incorporated, Metabasis Therapeutics, Inc., David F. Hale, as Stockholders’ Representative, and Mellon Investor Services LLC as Rights Agent, dated January 27, 2010
TR Beta CVR. The TR Beta CVR Agreement entitles each holder of a TR Beta CVR to receive a pro rata portion of a percentage of the net proceeds of any license or sale of Metabasis’ Thyroid Receptor Beta program in hyperlipidemia: 50% of such net proceeds if the licensing/sale transaction occurs by the sixth anniversary of the Merger; 40% if in the seventh year after the Merger; 30% if in the eighth year after the Merger; or 20% if in the ninth or tenth year after the Merger.
LGNXZ
=====
https://www.sec.gov/Archives/edgar/data/886163/000119312510015242/dex103.htm
Glucagon Contingent Value Rights Agreement, by and among Ligand Pharmaceuticals Incorporated, Metabasis Therapeutics, Inc., David F. Hale, as Stockholders’ Representative, and Mellon Investor Services LLC as Rights Agent, dated January 27, 2010
Glucagon CVR. The Glucagon CVR Agreement entitles each holder of a Glucagon CVR to receive a pro rata portion of a percentage of the net proceeds of any license or sale of Metabasis’ glucagon receptor antagonist program in diabetes: 50% of such net proceeds if the licensing/sale transaction occurs by the sixth anniversary of the Merger; 40% if in the seventh year after the Merger; 30% if in the eighth year after the Merger; or 20% if in the ninth or tenth year after the Merger.
https://www.businesswire.com/news/home/20100128005321/en/Ligand-Completes-Acquisition-Metabasis
LGNYZ
=====
https://www.sec.gov/Archives/edgar/data/886163/000119312510015242/dex104.htm
General Contingent Value Rights Agreement, by and among Ligand Pharmaceuticals Incorporated, Metabasis Therapeutics, Inc., David F. Hale, as Stockholders’ Representative, and Mellon Investor Services LLC as Rights Agent, dated January 27, 2010
General CVR. The General CVR Agreement entitles each holder of a General CVR to receive a pro rata portion of cash payments equal to the shortfall, if any, from defined spending thresholds of Ligand’s funding of further research and development of drug development programs acquired from Metabasis. The basic threshold is $8 million of funding within the first 42 months after the Merger. A secondary threshold (which shall be waived in certain circumstances) is $7 million of funding within the first 30 months after the Merger.
Good afternoon .... I am in the middle of doing a few things now but I will answer your question a little later if no one else does by then
guys, sorry i am novice here, but why have these LGND OTC plays have gone up few hundred % last 2 days. what's driving them? any quick 1-2 line replies are welcome. i have LGND in my regular shares and been a fan for long time but never looked at these warrant plays
Ok.. So I’ll stick to the main focus here. Will look for more good ones
We can throw a non CVR bio in here from time to time
PB Are bios plays that don’t have CVRs allowed to be talked about?
Greetings my friend. Gotta love new trends!
Followers
|
11
|
Posters
|
|
Posts (Today)
|
0
|
Posts (Total)
|
127
|
Created
|
04/05/20
|
Type
|
Free
|
Moderators WHITTENHALLJR makinezmoney |
Volume | |
Day Range: | |
Bid Price | |
Ask Price | |
Last Trade Time: |